Parenteral Nutrition Market Report
Parenteral Nutrition Market, By Type (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins, and Minerals), Application (Premature Infants, Neonates and Children, Geriatrics, Chronic Disease Patients), and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Parenteral Nutrition market. The historic years considered for the study are 2016-2019, the base year is 2020, and the forecast period is 2021-2026.
Parenteral Nutrition Market, By Type (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins, and Minerals), Application (Premature Infants, Neonates and Children, Geriatrics, Chronic Disease Patients), and Region ...
Impact of COVID-19 on Parenteral Nutrition Market
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Parenteral Nutrition market is projected to grow from USD 5.9 billion in 2020 to USD 8.1 billion by 2026 at a CAGR of around 5.6% during the forecast period.
Parenteral nutrition is defined because the feeding of nutritional products through veins to patients who don't seem to be able to eat enough food to keep up the great nutritional requirement of the body and private growth. Nutrients include carbohydrates, minerals, fat, vitamins, and other trace elements. These nutrients are delivered either peripherally or centrally, through superior vena cava.
Key players operating in the global Parenteral Nutrition market are-
The growth of the parenteral nutrition market is primarily driven by the increasing prevalence of chronic diseases due to changing lifestyles and unhealthy eating habits. Expanding the geriatric populace across geographies is likely to drive the growth of parenteral nutrition at a significant rate during the review period. In addition to this, factors such as the presence of a large number of malnourished children and a high natality rate are likely to augment the market growth substantially. Furthermore, rising demand for new product development is likely to create lucrative opportunities for the players operating in the global market in the coming years.
By type, the parenteral nutrition market has been bifurcated into premature infants, neonates and children, geriatrics, and chronic disease patients. Under these, the premature infants, neonates, and children segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period.
By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The segment growth is primarily attributed to the presence of advanced healthcare facilities coupled with the increasing prevalence of chronic diseases. The market growth in the Asia-Pacific region is expected to be driven by growing healthcare expenditure and increasing incidences of fatalities due to malnutrition.
The outbreak of the COVID-19 virus has affected the growth of the healthcare industry significantly. Stringent lockdown measures and restricted movement of people affected the product supply. However, the demand for vitamins increased to boost immunity.
Here is the list of the group of customers that the parenteral nutrition market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at firstname.lastname@example.org.
The parenteral nutrition market is expected to grow at an impressive CAGR of 5.6% in the coming years.
Baxter International Inc. (US), Hospira (US), B. Braun (Germany), Grifols International, S.A. (Spain), Fresenius Kabi (Germany), Otsuka Pharmaceutical Factory, Inc. (Japan), Actavis Generics (US) and Sichuan Kelun Pharmaceutical Co., Ltd (China) are among the key players in the parenteral nutrition market.
The premature infants, neonates, and children segment is expected to register significant growth in the parenteral nutrition market in the coming years.
The parenteral nutrition market size is expected to reach USD 8.1 billion in the foreseeable future.
North America accounted for the largest share in the parenteral nutrition market in 2020.
Parenteral nutrition distributors, Parenteral nutrition suppliers, Parenteral nutrition manufacturers, Logistics organizations, Government bodies are among the target audience in the parenteral nutrition market.